Post-vaccination Surveillance for Monitoring the Adverse Events Following Immunisation With QDENGA in a Real-world Setting in Malaysia (PRIME-Q)
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY
The main aim of this study is to collect the number and type of medical problems (adverse events) after vaccination with QDENGA in Malaysia and to learn more about such medical problems after vaccination. Another aim of this study is to collect the number of persons vaccinated with QDENGA who need to stay in the hospital because of severe dengue fever. No vaccination will be given as part of this study. The study will only collect data of persons already vaccinated with QDENGA who agree to participate.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 4
Healthy Volunteers: t
View:
• Participants who have received at least one dose of QDENGA vaccine in Malaysia during the study period.
• Participants or their legally authorized representative (LARs) with a functioning phone number.
Locations
Other Locations
Malaysia
Universiti Malaya
RECRUITING
Kuala Lumpur
Universiti Putra Malaysia
RECRUITING
Serdang
Contact Information
Primary
Takeda Contact
medinfoUS@takeda.com
+1-877-825-3327
Time Frame
Start Date: 2024-09-26
Estimated Completion Date: 2027-05-08
Participants
Target number of participants: 2000
Treatments
QDENGA Vaccinated
Participants who have received QDENGA vaccine will be prospectively surveyed and regularly contacted to obtain data for up to 15 months post-vaccination.
Related Therapeutic Areas
Sponsors
Leads: Takeda